Derace L. Schaffer, Director at Altimmune, Inc. (ALT), bought 93,352 shares at $2.22 ($206K) on 2017-08-23, disclosed to the SEC on 2017-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.02 | 690 | $1K | 0.7% |
| 2 | $2.10 | 5,958 | $13K | 6.1% |
| 3 | $2.22 | 43,352 | $96K | 46.6% |
| 4 | $2.22 | 43,352 | $96K | 46.6% |
| Total | $2.21 avg | 93,352 | $206K | 100% |
| Filing → |
| LNTH | SELL | 2019-04-03 | $244K | — | Filing → |
| ALT | BUY | 2018-01-02 | $375K | — | Filing → |
| ALT | BUY | 2017-12-27 | $352K | — | Filing → |